JP2007514003A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007514003A5 JP2007514003A5 JP2006545817A JP2006545817A JP2007514003A5 JP 2007514003 A5 JP2007514003 A5 JP 2007514003A5 JP 2006545817 A JP2006545817 A JP 2006545817A JP 2006545817 A JP2006545817 A JP 2006545817A JP 2007514003 A5 JP2007514003 A5 JP 2007514003A5
- Authority
- JP
- Japan
- Prior art keywords
- pyrimidin
- pyrazol
- group
- furyl
- amine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001875 compounds Chemical class 0.000 claims 34
- -1 hydroxycarbonyl groups Chemical group 0.000 claims 28
- 125000000217 alkyl group Chemical group 0.000 claims 25
- 125000005843 halogen group Chemical group 0.000 claims 18
- 125000000753 cycloalkyl group Chemical group 0.000 claims 16
- 125000001072 heteroaryl group Chemical group 0.000 claims 16
- 125000003545 alkoxy group Chemical group 0.000 claims 15
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 14
- 125000002941 2-furyl group Chemical group O1C([*])=C([H])C([H])=C1[H] 0.000 claims 11
- 125000003762 3,4-dimethoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C(OC([H])([H])[H])C([H])=C1* 0.000 claims 11
- 125000004527 pyrimidin-4-yl group Chemical group N1=CN=C(C=C1)* 0.000 claims 11
- 125000003118 aryl group Chemical group 0.000 claims 9
- 201000010099 disease Diseases 0.000 claims 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 9
- 230000001575 pathological effect Effects 0.000 claims 9
- 239000000203 mixture Substances 0.000 claims 8
- 125000004414 alkyl thio group Chemical group 0.000 claims 7
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 7
- 125000001424 substituent group Chemical group 0.000 claims 7
- 208000023105 Huntington disease Diseases 0.000 claims 6
- 208000018737 Parkinson disease Diseases 0.000 claims 6
- 208000005793 Restless legs syndrome Diseases 0.000 claims 6
- 206010042600 Supraventricular arrhythmias Diseases 0.000 claims 6
- 125000004183 alkoxy alkyl group Chemical group 0.000 claims 6
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims 6
- 230000001668 ameliorated effect Effects 0.000 claims 6
- 125000003277 amino group Chemical group 0.000 claims 6
- 230000008485 antagonism Effects 0.000 claims 6
- 125000004663 dialkyl amino group Chemical group 0.000 claims 6
- 229940052760 dopamine agonists Drugs 0.000 claims 6
- 239000003136 dopamine receptor stimulating agent Substances 0.000 claims 6
- 125000002541 furyl group Chemical group 0.000 claims 6
- 208000028867 ischemia Diseases 0.000 claims 6
- 230000007774 longterm Effects 0.000 claims 6
- 125000002560 nitrile group Chemical group 0.000 claims 6
- 125000003226 pyrazolyl group Chemical group 0.000 claims 6
- 208000019116 sleep disease Diseases 0.000 claims 6
- 102000009346 Adenosine receptors Human genes 0.000 claims 5
- 108050000203 Adenosine receptors Proteins 0.000 claims 5
- 208000014094 Dystonic disease Diseases 0.000 claims 5
- YLQBMQCUIZJEEH-UHFFFAOYSA-N Furan Chemical compound C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims 5
- 208000010118 dystonia Diseases 0.000 claims 5
- 125000002950 monocyclic group Chemical group 0.000 claims 5
- 125000001544 thienyl group Chemical group 0.000 claims 5
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 4
- 125000004076 pyridyl group Chemical group 0.000 claims 4
- 125000000335 thiazolyl group Chemical group 0.000 claims 4
- 125000001425 triazolyl group Chemical group 0.000 claims 4
- 208000009304 Acute Kidney Injury Diseases 0.000 claims 3
- 208000012661 Dyskinesia Diseases 0.000 claims 3
- 206010020751 Hypersensitivity Diseases 0.000 claims 3
- 208000022559 Inflammatory bowel disease Diseases 0.000 claims 3
- 208000007201 Myocardial reperfusion injury Diseases 0.000 claims 3
- 208000008589 Obesity Diseases 0.000 claims 3
- 208000033626 Renal failure acute Diseases 0.000 claims 3
- 206010039710 Scleroderma Diseases 0.000 claims 3
- 208000024780 Urticaria Diseases 0.000 claims 3
- 201000011040 acute kidney failure Diseases 0.000 claims 3
- 208000012998 acute renal failure Diseases 0.000 claims 3
- 208000030961 allergic reaction Diseases 0.000 claims 3
- 206010003246 arthritis Diseases 0.000 claims 3
- 208000006673 asthma Diseases 0.000 claims 3
- 230000005784 autoimmunity Effects 0.000 claims 3
- 206010012601 diabetes mellitus Diseases 0.000 claims 3
- 125000001188 haloalkyl group Chemical group 0.000 claims 3
- 125000002768 hydroxyalkyl group Chemical group 0.000 claims 3
- 235000020824 obesity Nutrition 0.000 claims 3
- 206010039083 rhinitis Diseases 0.000 claims 3
- VQKFNUFAXTZWDK-UHFFFAOYSA-N 2-Methylfuran Chemical compound CC1=CC=CO1 VQKFNUFAXTZWDK-UHFFFAOYSA-N 0.000 claims 2
- 125000000175 2-thienyl group Chemical group S1C([*])=C([H])C([H])=C1[H] 0.000 claims 2
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 claims 2
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 claims 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims 2
- WTKZEGDFNFYCGP-UHFFFAOYSA-N Pyrazole Chemical compound C=1C=NNC=1 WTKZEGDFNFYCGP-UHFFFAOYSA-N 0.000 claims 2
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical class C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 claims 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 claims 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 2
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 125000002883 imidazolyl group Chemical group 0.000 claims 2
- 239000003112 inhibitor Substances 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 125000002911 monocyclic heterocycle group Chemical group 0.000 claims 2
- VRYXOMHGBTVLKQ-UHFFFAOYSA-N n-[2-(3,5-dimethylpyrazol-1-yl)-6-(furan-2-yl)pyrimidin-4-yl]propanamide Chemical compound N=1C(NC(=O)CC)=CC(C=2OC=CC=2)=NC=1N1N=C(C)C=C1C VRYXOMHGBTVLKQ-UHFFFAOYSA-N 0.000 claims 2
- 229910052757 nitrogen Inorganic materials 0.000 claims 2
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 2
- 125000002971 oxazolyl group Chemical group 0.000 claims 2
- 125000003367 polycyclic group Chemical group 0.000 claims 2
- 125000003373 pyrazinyl group Chemical group 0.000 claims 2
- 125000002098 pyridazinyl group Chemical group 0.000 claims 2
- 125000000714 pyrimidinyl group Chemical group 0.000 claims 2
- XIJCRIZVIMXANU-SNVBAGLBSA-N (2r)-2-[(6-pyrazol-1-yl-2-thiophen-2-ylpyrimidin-4-yl)amino]propan-1-ol Chemical compound N=1C(N[C@@H](CO)C)=CC(N2N=CC=C2)=NC=1C1=CC=CS1 XIJCRIZVIMXANU-SNVBAGLBSA-N 0.000 claims 1
- KHJJDNGWRUWDLQ-SNVBAGLBSA-N (2r)-2-[[2-(furan-2-yl)-6-pyrazol-1-ylpyrimidin-4-yl]amino]propan-1-ol Chemical compound N=1C(N[C@@H](CO)C)=CC(N2N=CC=C2)=NC=1C1=CC=CO1 KHJJDNGWRUWDLQ-SNVBAGLBSA-N 0.000 claims 1
- OAOARXASUKGEJZ-AAFJCEBUSA-N (2s)-n-[2-(furan-2-yl)-6-pyrazol-1-ylpyrimidin-4-yl]-2-phenylcyclopropane-1-carboxamide Chemical compound C1([C@H](C1)C=1C=CC=CC=1)C(=O)NC(N=1)=CC(N2N=CC=C2)=NC=1C1=CC=CO1 OAOARXASUKGEJZ-AAFJCEBUSA-N 0.000 claims 1
- KHJQWZPZUNQEAC-VQHVLOKHSA-N (e)-3-(3,4-dimethoxyphenyl)-n-[2-(furan-2-yl)-6-pyrazol-1-ylpyrimidin-4-yl]prop-2-enamide Chemical compound C1=C(OC)C(OC)=CC=C1\C=C\C(=O)NC1=CC(N2N=CC=C2)=NC(C=2OC=CC=2)=N1 KHJQWZPZUNQEAC-VQHVLOKHSA-N 0.000 claims 1
- AFCDLIURZOFCCW-UHFFFAOYSA-N 1-[2-(furan-2-yl)-6-pyrazol-1-ylpyrimidin-4-yl]-3-(2-phenylethyl)urea Chemical compound C=1C(N2N=CC=C2)=NC(C=2OC=CC=2)=NC=1NC(=O)NCCC1=CC=CC=C1 AFCDLIURZOFCCW-UHFFFAOYSA-N 0.000 claims 1
- VIKRCAWBIVSVDX-UHFFFAOYSA-N 1-[2-(furan-2-yl)-6-pyrazol-1-ylpyrimidin-4-yl]-3-(4-methoxyphenyl)urea Chemical compound C1=CC(OC)=CC=C1NC(=O)NC1=CC(N2N=CC=C2)=NC(C=2OC=CC=2)=N1 VIKRCAWBIVSVDX-UHFFFAOYSA-N 0.000 claims 1
- VOQWSGBQGKEQEI-UHFFFAOYSA-N 1-[2-(furan-2-yl)-6-pyrazol-1-ylpyrimidin-4-yl]-3-propan-2-ylurea Chemical compound N=1C(NC(=O)NC(C)C)=CC(N2N=CC=C2)=NC=1C1=CC=CO1 VOQWSGBQGKEQEI-UHFFFAOYSA-N 0.000 claims 1
- QOKKSLWQQLCNLE-UHFFFAOYSA-N 1-[2-(furan-2-yl)-6-pyrazol-1-ylpyrimidin-4-yl]-3-propylurea Chemical compound N=1C(NC(=O)NCCC)=CC(N2N=CC=C2)=NC=1C1=CC=CO1 QOKKSLWQQLCNLE-UHFFFAOYSA-N 0.000 claims 1
- LOOKOYHOWURFKU-UHFFFAOYSA-N 1-benzyl-3-[2-(furan-2-yl)-6-pyrazol-1-ylpyrimidin-4-yl]urea Chemical compound C=1C(N2N=CC=C2)=NC(C=2OC=CC=2)=NC=1NC(=O)NCC1=CC=CC=C1 LOOKOYHOWURFKU-UHFFFAOYSA-N 0.000 claims 1
- ZNSULQSSJAZWSM-UHFFFAOYSA-N 1-cyclopentyl-3-[2-(furan-2-yl)-6-pyrazol-1-ylpyrimidin-4-yl]urea Chemical compound C=1C(N2N=CC=C2)=NC(C=2OC=CC=2)=NC=1NC(=O)NC1CCCC1 ZNSULQSSJAZWSM-UHFFFAOYSA-N 0.000 claims 1
- GVXRARNXFAXPGX-UHFFFAOYSA-N 2,6-bis(furan-2-yl)pyrimidin-4-amine Chemical compound N=1C(N)=CC(C=2OC=CC=2)=NC=1C1=CC=CO1 GVXRARNXFAXPGX-UHFFFAOYSA-N 0.000 claims 1
- ZEYJFIBYWIEBQO-UHFFFAOYSA-N 2,6-difluoro-n-[2-(furan-2-yl)-6-pyrazol-1-ylpyrimidin-4-yl]benzamide Chemical compound FC1=CC=CC(F)=C1C(=O)NC1=CC(N2N=CC=C2)=NC(C=2OC=CC=2)=N1 ZEYJFIBYWIEBQO-UHFFFAOYSA-N 0.000 claims 1
- JZSGKIFLXMFQHF-UHFFFAOYSA-N 2,6-dipyridin-4-ylpyrimidin-4-amine Chemical compound N=1C(N)=CC(C=2C=CN=CC=2)=NC=1C1=CC=NC=C1 JZSGKIFLXMFQHF-UHFFFAOYSA-N 0.000 claims 1
- FGRVBMHEWSSSOW-UHFFFAOYSA-N 2-(3,4-dihydroxyphenyl)-n-[2-(furan-2-yl)-6-pyrazol-1-ylpyrimidin-4-yl]acetamide Chemical compound C1=C(O)C(O)=CC=C1CC(=O)NC1=CC(N2N=CC=C2)=NC(C=2OC=CC=2)=N1 FGRVBMHEWSSSOW-UHFFFAOYSA-N 0.000 claims 1
- DBYYNDHZNCWHER-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-n-[2-(furan-2-yl)-6-pyrazol-1-ylpyrimidin-4-yl]acetamide Chemical compound C1=C(OC)C(OC)=CC=C1CC(=O)NC1=CC(N2N=CC=C2)=NC(C=2OC=CC=2)=N1 DBYYNDHZNCWHER-UHFFFAOYSA-N 0.000 claims 1
- QGIAQYGBAVCKFF-UHFFFAOYSA-N 2-(3,5-dimethylpyrazol-1-yl)-6-(furan-2-yl)pyrimidin-4-amine Chemical compound N1=C(C)C=C(C)N1C1=NC(N)=CC(C=2OC=CC=2)=N1 QGIAQYGBAVCKFF-UHFFFAOYSA-N 0.000 claims 1
- INYDWBOVELBLTP-UHFFFAOYSA-N 2-(3,5-dimethylpyrazol-1-yl)-6-pyridin-2-ylpyrimidin-4-amine Chemical compound N1=C(C)C=C(C)N1C1=NC(N)=CC(C=2N=CC=CC=2)=N1 INYDWBOVELBLTP-UHFFFAOYSA-N 0.000 claims 1
- AJQAQAZBCMCTBN-UHFFFAOYSA-N 2-(3,5-dimethylpyrazol-1-yl)-6-pyridin-3-ylpyrimidin-4-amine Chemical compound N1=C(C)C=C(C)N1C1=NC(N)=CC(C=2C=NC=CC=2)=N1 AJQAQAZBCMCTBN-UHFFFAOYSA-N 0.000 claims 1
- WTHLNTSFPPMPSD-UHFFFAOYSA-N 2-(3-methylpyridin-2-yl)-6-pyrazol-1-ylpyrimidin-4-amine Chemical compound CC1=CC=CN=C1C1=NC(N)=CC(N2N=CC=C2)=N1 WTHLNTSFPPMPSD-UHFFFAOYSA-N 0.000 claims 1
- TXMREBGHWILILM-UHFFFAOYSA-N 2-(4-cyclobutyloxy-3-methoxyphenyl)-n-[2-(furan-2-yl)-6-pyrazol-1-ylpyrimidin-4-yl]acetamide Chemical compound C=1C=C(OC2CCC2)C(OC)=CC=1CC(=O)NC(N=1)=CC(N2N=CC=C2)=NC=1C1=CC=CO1 TXMREBGHWILILM-UHFFFAOYSA-N 0.000 claims 1
- CRUWUNMTMPKJLK-UHFFFAOYSA-N 2-(5-bromofuran-2-yl)-6-pyrazol-1-ylpyrimidin-4-amine Chemical compound N=1C(N)=CC(N2N=CC=C2)=NC=1C1=CC=C(Br)O1 CRUWUNMTMPKJLK-UHFFFAOYSA-N 0.000 claims 1
- JZGGOMLLZAAELR-UHFFFAOYSA-N 2-(5-chlorofuran-2-yl)-6-pyrazol-1-ylpyrimidin-4-amine Chemical compound N=1C(N)=CC(N2N=CC=C2)=NC=1C1=CC=C(Cl)O1 JZGGOMLLZAAELR-UHFFFAOYSA-N 0.000 claims 1
- QUPRWOOSTWVZET-UHFFFAOYSA-N 2-(5-methylfuran-2-yl)-6-(1,3-thiazol-2-yl)pyrimidin-4-amine Chemical compound O1C(C)=CC=C1C1=NC(N)=CC(C=2SC=CN=2)=N1 QUPRWOOSTWVZET-UHFFFAOYSA-N 0.000 claims 1
- DJECROXLUBKSKW-UHFFFAOYSA-N 2-(5-methylfuran-2-yl)-6-pyrazol-1-ylpyrimidin-4-amine Chemical compound O1C(C)=CC=C1C1=NC(N)=CC(N2N=CC=C2)=N1 DJECROXLUBKSKW-UHFFFAOYSA-N 0.000 claims 1
- BXANNUDVSKOUNE-UHFFFAOYSA-N 2-(dimethylamino)-n-[2-(furan-2-yl)-6-pyrazol-1-ylpyrimidin-4-yl]acetamide Chemical compound N=1C(NC(=O)CN(C)C)=CC(N2N=CC=C2)=NC=1C1=CC=CO1 BXANNUDVSKOUNE-UHFFFAOYSA-N 0.000 claims 1
- FYYPRUOUFXXRIX-UHFFFAOYSA-N 2-(furan-2-yl)-6-(1,2,4-triazol-1-yl)pyrimidin-4-amine Chemical compound N=1C(N)=CC(N2N=CN=C2)=NC=1C1=CC=CO1 FYYPRUOUFXXRIX-UHFFFAOYSA-N 0.000 claims 1
- AUIZMHDUSGWFRE-UHFFFAOYSA-N 2-(furan-2-yl)-6-(1,3-thiazol-2-yl)pyrimidin-4-amine Chemical compound N=1C(N)=CC(C=2SC=CN=2)=NC=1C1=CC=CO1 AUIZMHDUSGWFRE-UHFFFAOYSA-N 0.000 claims 1
- OILPRDXDLMCWAJ-UHFFFAOYSA-N 2-(furan-2-yl)-6-(3-methylpyrazol-1-yl)pyrimidin-4-amine Chemical compound N1=C(C)C=CN1C1=CC(N)=NC(C=2OC=CC=2)=N1 OILPRDXDLMCWAJ-UHFFFAOYSA-N 0.000 claims 1
- HXBWPUBAQKDWQT-UHFFFAOYSA-N 2-(furan-2-yl)-6-(4-methylpyrazol-1-yl)pyrimidin-4-amine Chemical compound C1=C(C)C=NN1C1=CC(N)=NC(C=2OC=CC=2)=N1 HXBWPUBAQKDWQT-UHFFFAOYSA-N 0.000 claims 1
- FMKSEVMTAQXSPN-UHFFFAOYSA-N 2-(furan-2-yl)-6-(triazol-1-yl)pyrimidin-4-amine Chemical compound N=1C(N)=CC(N2N=NC=C2)=NC=1C1=CC=CO1 FMKSEVMTAQXSPN-UHFFFAOYSA-N 0.000 claims 1
- ISHYNMIQUAJEEQ-UHFFFAOYSA-N 2-(furan-2-yl)-6-(triazol-2-yl)pyrimidin-4-amine Chemical compound N=1C(N)=CC(N2N=CC=N2)=NC=1C1=CC=CO1 ISHYNMIQUAJEEQ-UHFFFAOYSA-N 0.000 claims 1
- NQAOZVLMZTZKSG-UHFFFAOYSA-N 2-(furan-2-yl)-6-[3-(trifluoromethyl)pyrazol-1-yl]pyrimidin-4-amine Chemical compound N=1C(N)=CC(N2N=C(C=C2)C(F)(F)F)=NC=1C1=CC=CO1 NQAOZVLMZTZKSG-UHFFFAOYSA-N 0.000 claims 1
- IXPMFSMPIUDXOC-UHFFFAOYSA-N 2-(furan-2-yl)-6-[5-methyl-3-(trifluoromethyl)pyrazol-1-yl]pyrimidin-4-amine Chemical compound CC1=CC(C(F)(F)F)=NN1C1=CC(N)=NC(C=2OC=CC=2)=N1 IXPMFSMPIUDXOC-UHFFFAOYSA-N 0.000 claims 1
- RCXUJYRCTFQMAI-UHFFFAOYSA-N 2-(furan-2-yl)-6-pyrazol-1-yl-n-(2-pyridin-2-ylethyl)pyrimidin-4-amine Chemical compound C=1C(N2N=CC=C2)=NC(C=2OC=CC=2)=NC=1NCCC1=CC=CC=N1 RCXUJYRCTFQMAI-UHFFFAOYSA-N 0.000 claims 1
- ODVPRVAZJZTHNZ-UHFFFAOYSA-N 2-(furan-2-yl)-6-pyrazol-1-yl-n-(2-pyridin-3-ylethyl)pyrimidin-4-amine Chemical compound C=1C(N2N=CC=C2)=NC(C=2OC=CC=2)=NC=1NCCC1=CC=CN=C1 ODVPRVAZJZTHNZ-UHFFFAOYSA-N 0.000 claims 1
- SSPIGFDAVQVRCH-UHFFFAOYSA-N 2-(furan-2-yl)-6-pyrazol-1-ylpyrimidin-4-amine Chemical compound N=1C(N)=CC(N2N=CC=C2)=NC=1C1=CC=CO1 SSPIGFDAVQVRCH-UHFFFAOYSA-N 0.000 claims 1
- PCRHJBYOAODCMX-UHFFFAOYSA-N 2-(furan-2-yl)-6-pyridin-3-ylpyrimidin-4-amine Chemical compound N=1C(N)=CC(C=2C=NC=CC=2)=NC=1C1=CC=CO1 PCRHJBYOAODCMX-UHFFFAOYSA-N 0.000 claims 1
- UBSWNUSPOFXZAA-UHFFFAOYSA-N 2-(furan-2-yl)-n-(3-imidazol-1-ylpropyl)-6-pyrazol-1-ylpyrimidin-4-amine Chemical compound C1=CN=CN1CCCNC(N=1)=CC(N2N=CC=C2)=NC=1C1=CC=CO1 UBSWNUSPOFXZAA-UHFFFAOYSA-N 0.000 claims 1
- BKRCHXQGKCBWIB-UHFFFAOYSA-N 2-(furan-2-yl)-n-(3-phenylpropyl)-6-pyrazol-1-ylpyrimidin-4-amine Chemical compound C=1C=CC=CC=1CCCNC(N=1)=CC(N2N=CC=C2)=NC=1C1=CC=CO1 BKRCHXQGKCBWIB-UHFFFAOYSA-N 0.000 claims 1
- IRBGGMJCNGNPHI-UHFFFAOYSA-N 2-(furan-2-yl)-n-[2-(4-methoxyphenyl)ethyl]-6-pyrazol-1-ylpyrimidin-4-amine Chemical compound C1=CC(OC)=CC=C1CCNC1=CC(N2N=CC=C2)=NC(C=2OC=CC=2)=N1 IRBGGMJCNGNPHI-UHFFFAOYSA-N 0.000 claims 1
- FZTAWFXQZWOQBA-UHFFFAOYSA-N 2-(furan-2-yl)-n-methyl-6-(1,3-thiazol-2-yl)pyrimidin-4-amine Chemical compound N=1C(NC)=CC(C=2SC=CN=2)=NC=1C1=CC=CO1 FZTAWFXQZWOQBA-UHFFFAOYSA-N 0.000 claims 1
- 125000000022 2-aminoethyl group Chemical group [H]C([*])([H])C([H])([H])N([H])[H] 0.000 claims 1
- HAZHCCVOGDRQAC-UHFFFAOYSA-N 2-chloro-n-[2-(furan-2-yl)-6-pyrazol-1-ylpyrimidin-4-yl]-2-phenylacetamide Chemical compound C=1C=CC=CC=1C(Cl)C(=O)NC(N=1)=CC(N2N=CC=C2)=NC=1C1=CC=CO1 HAZHCCVOGDRQAC-UHFFFAOYSA-N 0.000 claims 1
- BDAOCUQCPGGNQA-UHFFFAOYSA-N 2-pyrazol-1-yl-6-pyridin-2-ylpyrimidin-4-amine Chemical compound N=1C(N)=CC(C=2N=CC=CC=2)=NC=1N1C=CC=N1 BDAOCUQCPGGNQA-UHFFFAOYSA-N 0.000 claims 1
- QKLXMJSSWROXOB-UHFFFAOYSA-N 2-pyrazol-1-yl-6-pyridin-3-ylpyrimidin-4-amine Chemical compound N=1C(N)=CC(C=2C=NC=CC=2)=NC=1N1C=CC=N1 QKLXMJSSWROXOB-UHFFFAOYSA-N 0.000 claims 1
- HGOBWUWXWQEDRJ-UHFFFAOYSA-N 2-pyrazol-1-yl-6-pyridin-4-ylpyrimidin-4-amine Chemical compound N=1C(N)=CC(C=2C=CN=CC=2)=NC=1N1C=CC=N1 HGOBWUWXWQEDRJ-UHFFFAOYSA-N 0.000 claims 1
- IGWKIVBFQGBBPN-UHFFFAOYSA-N 2-pyridin-3-yl-6-(1,2,4-triazol-1-yl)pyrimidin-4-amine Chemical compound N=1C(N)=CC(N2N=CN=C2)=NC=1C1=CC=CN=C1 IGWKIVBFQGBBPN-UHFFFAOYSA-N 0.000 claims 1
- BKAAUNZOEAYUCW-UHFFFAOYSA-N 2-thiophen-2-yl-6-(1,2,4-triazol-1-yl)pyrimidin-4-amine Chemical compound N=1C(N)=CC(N2N=CN=C2)=NC=1C1=CC=CS1 BKAAUNZOEAYUCW-UHFFFAOYSA-N 0.000 claims 1
- BSTQCOAUKNXSQA-UHFFFAOYSA-N 3,3,3-trifluoro-n-(6-pyrazol-1-yl-2-thiophen-2-ylpyrimidin-4-yl)propanamide Chemical compound N=1C(NC(=O)CC(F)(F)F)=CC(N2N=CC=C2)=NC=1C1=CC=CS1 BSTQCOAUKNXSQA-UHFFFAOYSA-N 0.000 claims 1
- OXIIWNQWRYCCET-UHFFFAOYSA-N 3,3,3-trifluoro-n-[2-(furan-2-yl)-6-(1,2,4-triazol-1-yl)pyrimidin-4-yl]propanamide Chemical compound N=1C(NC(=O)CC(F)(F)F)=CC(N2N=CN=C2)=NC=1C1=CC=CO1 OXIIWNQWRYCCET-UHFFFAOYSA-N 0.000 claims 1
- LUVBJGUWYOABSB-UHFFFAOYSA-N 3,3,3-trifluoro-n-[2-(furan-2-yl)-6-pyrazol-1-ylpyrimidin-4-yl]propanamide Chemical compound N=1C(NC(=O)CC(F)(F)F)=CC(N2N=CC=C2)=NC=1C1=CC=CO1 LUVBJGUWYOABSB-UHFFFAOYSA-N 0.000 claims 1
- DVQUSNRPKUMTFS-UHFFFAOYSA-N 3,3,3-trifluoro-n-[6-(furan-2-yl)-2-pyrazol-1-ylpyrimidin-4-yl]propanamide Chemical compound N=1C(NC(=O)CC(F)(F)F)=CC(C=2OC=CC=2)=NC=1N1C=CC=N1 DVQUSNRPKUMTFS-UHFFFAOYSA-N 0.000 claims 1
- 125000004189 3,4-dichlorophenyl group Chemical group [H]C1=C([H])C(Cl)=C(Cl)C([H])=C1* 0.000 claims 1
- QSKVXNOSLFNGNG-UHFFFAOYSA-N 3-[(6-pyrazol-1-yl-2-thiophen-2-ylpyrimidin-4-yl)amino]propan-1-ol Chemical compound N=1C(NCCCO)=CC(N2N=CC=C2)=NC=1C1=CC=CS1 QSKVXNOSLFNGNG-UHFFFAOYSA-N 0.000 claims 1
- RGLFDJQEFHUAQA-UHFFFAOYSA-N 3-[[2-(furan-2-yl)-6-pyrazol-1-ylpyrimidin-4-yl]amino]propan-1-ol Chemical compound N=1C(NCCCO)=CC(N2N=CC=C2)=NC=1C1=CC=CO1 RGLFDJQEFHUAQA-UHFFFAOYSA-N 0.000 claims 1
- IMNIIEVLKDTHAP-UHFFFAOYSA-N 3-phenoxy-n-(6-pyrazol-1-yl-2-thiophen-2-ylpyrimidin-4-yl)propanamide Chemical compound C=1C(N2N=CC=C2)=NC(C=2SC=CC=2)=NC=1NC(=O)CCOC1=CC=CC=C1 IMNIIEVLKDTHAP-UHFFFAOYSA-N 0.000 claims 1
- BCRKVDCNUKZXGH-UHFFFAOYSA-N 3-phenyl-n-(6-pyrazol-1-yl-2-thiophen-2-ylpyrimidin-4-yl)propanamide Chemical compound C=1C(N2N=CC=C2)=NC(C=2SC=CC=2)=NC=1NC(=O)CCC1=CC=CC=C1 BCRKVDCNUKZXGH-UHFFFAOYSA-N 0.000 claims 1
- VXAUDFRDCFXSPE-UHFFFAOYSA-N 6-(1,3-benzothiazol-2-yl)-2-(furan-2-yl)pyrimidin-4-amine Chemical compound N=1C(N)=CC(C=2SC3=CC=CC=C3N=2)=NC=1C1=CC=CO1 VXAUDFRDCFXSPE-UHFFFAOYSA-N 0.000 claims 1
- ZIBRJXHDVNQPTF-UHFFFAOYSA-N 6-(1,3-thiazol-2-yl)-2-thiophen-2-ylpyrimidin-4-amine Chemical compound N=1C(N)=CC(C=2SC=CN=2)=NC=1C1=CC=CS1 ZIBRJXHDVNQPTF-UHFFFAOYSA-N 0.000 claims 1
- COMLAOVCRZSMJA-UHFFFAOYSA-N 6-(3,5-dimethylpyrazol-1-yl)-2-(furan-2-yl)pyrimidin-4-amine Chemical compound N1=C(C)C=C(C)N1C1=CC(N)=NC(C=2OC=CC=2)=N1 COMLAOVCRZSMJA-UHFFFAOYSA-N 0.000 claims 1
- CWPYVABZPIGXTH-UHFFFAOYSA-N 6-(3,5-dimethylpyrazol-1-yl)-2-pyridin-3-ylpyrimidin-4-amine Chemical compound N1=C(C)C=C(C)N1C1=CC(N)=NC(C=2C=NC=CC=2)=N1 CWPYVABZPIGXTH-UHFFFAOYSA-N 0.000 claims 1
- BGYGJRXYPQUPQX-UHFFFAOYSA-N 6-(3,5-dimethylpyrazol-1-yl)-2-pyridin-4-ylpyrimidin-4-amine Chemical compound N1=C(C)C=C(C)N1C1=CC(N)=NC(C=2C=CN=CC=2)=N1 BGYGJRXYPQUPQX-UHFFFAOYSA-N 0.000 claims 1
- YABLLXWMAYEMRM-UHFFFAOYSA-N 6-(3,5-dimethylpyrazol-1-yl)-2-thiophen-2-ylpyrimidin-4-amine Chemical compound N1=C(C)C=C(C)N1C1=CC(N)=NC(C=2SC=CC=2)=N1 YABLLXWMAYEMRM-UHFFFAOYSA-N 0.000 claims 1
- VAAULLJTPQGTMH-UHFFFAOYSA-N 6-(furan-2-yl)-2-(1,2,4-triazol-1-yl)pyrimidin-4-amine Chemical compound N=1C(N)=CC(C=2OC=CC=2)=NC=1N1C=NC=N1 VAAULLJTPQGTMH-UHFFFAOYSA-N 0.000 claims 1
- YIGQEWGAZFMRCE-UHFFFAOYSA-N 6-(furan-2-yl)-2-(1,3-thiazol-2-yl)pyrimidin-4-amine Chemical compound N=1C(N)=CC(C=2OC=CC=2)=NC=1C1=NC=CS1 YIGQEWGAZFMRCE-UHFFFAOYSA-N 0.000 claims 1
- MMHYMZYSWVGTBU-UHFFFAOYSA-N 6-(furan-2-yl)-2-pyrazol-1-ylpyrimidin-4-amine Chemical compound N=1C(N)=CC(C=2OC=CC=2)=NC=1N1C=CC=N1 MMHYMZYSWVGTBU-UHFFFAOYSA-N 0.000 claims 1
- ISMMTVODXRNFME-UHFFFAOYSA-N 6-(furan-2-yl)-2-pyridin-2-ylpyrimidin-4-amine Chemical compound N=1C(N)=CC(C=2OC=CC=2)=NC=1C1=CC=CC=N1 ISMMTVODXRNFME-UHFFFAOYSA-N 0.000 claims 1
- OWINVEKYUSLTND-UHFFFAOYSA-N 6-(furan-2-yl)-2-pyridin-3-ylpyrimidin-4-amine Chemical compound N=1C(N)=CC(C=2OC=CC=2)=NC=1C1=CC=CN=C1 OWINVEKYUSLTND-UHFFFAOYSA-N 0.000 claims 1
- AJONFBYTSROCNO-UHFFFAOYSA-N 6-(furan-2-yl)-2-pyridin-4-ylpyrimidin-4-amine Chemical compound N=1C(N)=CC(C=2OC=CC=2)=NC=1C1=CC=NC=C1 AJONFBYTSROCNO-UHFFFAOYSA-N 0.000 claims 1
- QWKFSXCXCRBUQK-UHFFFAOYSA-N 6-(furan-2-yl)-n-(2-pyridin-3-ylethyl)-2-(1,3-thiazol-2-yl)pyrimidin-4-amine Chemical compound C=1C(C=2OC=CC=2)=NC(C=2SC=CN=2)=NC=1NCCC1=CC=CN=C1 QWKFSXCXCRBUQK-UHFFFAOYSA-N 0.000 claims 1
- JSJHYWXPEHHPES-UHFFFAOYSA-N 6-pyrazol-1-yl-2-(1,3-thiazol-2-yl)pyrimidin-4-amine Chemical compound N=1C(N)=CC(N2N=CC=C2)=NC=1C1=NC=CS1 JSJHYWXPEHHPES-UHFFFAOYSA-N 0.000 claims 1
- MNLLVWRGCWZPGP-UHFFFAOYSA-N 6-pyrazol-1-yl-2-pyridin-3-ylpyrimidin-4-amine Chemical compound N=1C(N)=CC(N2N=CC=C2)=NC=1C1=CC=CN=C1 MNLLVWRGCWZPGP-UHFFFAOYSA-N 0.000 claims 1
- NDQUZEBZQODQEN-UHFFFAOYSA-N 6-pyrazol-1-yl-2-thiophen-2-ylpyrimidin-4-amine Chemical compound N=1C(N)=CC(N2N=CC=C2)=NC=1C1=CC=CS1 NDQUZEBZQODQEN-UHFFFAOYSA-N 0.000 claims 1
- GSBFUWHUBAHWNV-UHFFFAOYSA-N 6-pyrazol-1-yl-n-(2-pyridin-2-ylethyl)-2-thiophen-2-ylpyrimidin-4-amine Chemical compound C=1C(N2N=CC=C2)=NC(C=2SC=CC=2)=NC=1NCCC1=CC=CC=N1 GSBFUWHUBAHWNV-UHFFFAOYSA-N 0.000 claims 1
- LRBBDGQOZRAVGJ-UHFFFAOYSA-N 6-pyrazol-1-yl-n-(2-pyridin-3-ylethyl)-2-thiophen-2-ylpyrimidin-4-amine Chemical compound C=1C(N2N=CC=C2)=NC(C=2SC=CC=2)=NC=1NCCC1=CC=CN=C1 LRBBDGQOZRAVGJ-UHFFFAOYSA-N 0.000 claims 1
- ARAQYBSWWVLTHW-UHFFFAOYSA-N C(N)(OC(C1CCCC1)C1=NC(=NC(=C1)N1N=CC=C1)C=1OC=CC1)=O Chemical compound C(N)(OC(C1CCCC1)C1=NC(=NC(=C1)N1N=CC=C1)C=1OC=CC1)=O ARAQYBSWWVLTHW-UHFFFAOYSA-N 0.000 claims 1
- DEBUVSCVSXGZRM-UHFFFAOYSA-N C(N)(OC(C=1C=NC=CC1)C1=NC(=NC(=C1)N1N=CC=C1)C=1OC=CC1)=O Chemical compound C(N)(OC(C=1C=NC=CC1)C1=NC(=NC(=C1)N1N=CC=C1)C=1OC=CC1)=O DEBUVSCVSXGZRM-UHFFFAOYSA-N 0.000 claims 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 claims 1
- 229940099362 Catechol O methyltransferase inhibitor Drugs 0.000 claims 1
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 claims 1
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 claims 1
- WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 claims 1
- 102000010909 Monoamine Oxidase Human genes 0.000 claims 1
- 108010062431 Monoamine oxidase Proteins 0.000 claims 1
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 claims 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims 1
- 229960005305 adenosine Drugs 0.000 claims 1
- 150000001412 amines Chemical class 0.000 claims 1
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 claims 1
- 239000004202 carbamide Substances 0.000 claims 1
- 239000003543 catechol methyltransferase inhibitor Substances 0.000 claims 1
- 125000004093 cyano group Chemical group *C#N 0.000 claims 1
- 125000004122 cyclic group Chemical group 0.000 claims 1
- 125000001316 cycloalkyl alkyl group Chemical group 0.000 claims 1
- 125000004985 dialkyl amino alkyl group Chemical group 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 229960003638 dopamine Drugs 0.000 claims 1
- 239000003210 dopamine receptor blocking agent Substances 0.000 claims 1
- 150000002240 furans Chemical class 0.000 claims 1
- 125000004446 heteroarylalkyl group Chemical group 0.000 claims 1
- 125000005326 heteroaryloxy alkyl group Chemical group 0.000 claims 1
- BYVISLIPBKNMQZ-UHFFFAOYSA-N n'-[2-(furan-2-yl)-6-pyrazol-1-ylpyrimidin-4-yl]ethane-1,2-diamine Chemical compound N=1C(NCCN)=CC(N2N=CC=C2)=NC=1C1=CC=CO1 BYVISLIPBKNMQZ-UHFFFAOYSA-N 0.000 claims 1
- XOFRTQBPJBUNBO-UHFFFAOYSA-N n-(2,5-dimethoxyphenyl)-2,6-dipyridin-2-ylpyrimidin-4-amine Chemical compound COC1=CC=C(OC)C(NC=2N=C(N=C(C=2)C=2N=CC=CC=2)C=2N=CC=CC=2)=C1 XOFRTQBPJBUNBO-UHFFFAOYSA-N 0.000 claims 1
- GNEJIQJEFCDLAA-UHFFFAOYSA-N n-(2,5-dimethylphenyl)-2,6-dipyridin-2-ylpyrimidin-4-amine Chemical compound CC1=CC=C(C)C(NC=2N=C(N=C(C=2)C=2N=CC=CC=2)C=2N=CC=CC=2)=C1 GNEJIQJEFCDLAA-UHFFFAOYSA-N 0.000 claims 1
- LZONKNBQISQPPO-UHFFFAOYSA-N n-(2-methoxy-5-methylphenyl)-2,6-dipyridin-2-ylpyrimidin-4-amine Chemical compound COC1=CC=C(C)C=C1NC1=CC(C=2N=CC=CC=2)=NC(C=2N=CC=CC=2)=N1 LZONKNBQISQPPO-UHFFFAOYSA-N 0.000 claims 1
- ILTIDTDBHZAEQK-UHFFFAOYSA-N n-(2-pyrazol-1-yl-6-pyridin-3-ylpyrimidin-4-yl)propanamide Chemical compound N=1C(NC(=O)CC)=CC(C=2C=NC=CC=2)=NC=1N1C=CC=N1 ILTIDTDBHZAEQK-UHFFFAOYSA-N 0.000 claims 1
- GYDZJSDARLIFQQ-UHFFFAOYSA-N n-(3-imidazol-1-ylpropyl)-6-pyrazol-1-yl-2-thiophen-2-ylpyrimidin-4-amine Chemical compound C1=CN=CN1CCCNC(N=1)=CC(N2N=CC=C2)=NC=1C1=CC=CS1 GYDZJSDARLIFQQ-UHFFFAOYSA-N 0.000 claims 1
- CROPXVXORWPZNY-UHFFFAOYSA-N n-(3-methoxyphenyl)-2,6-dipyridin-2-ylpyrimidin-4-amine Chemical compound COC1=CC=CC(NC=2N=C(N=C(C=2)C=2N=CC=CC=2)C=2N=CC=CC=2)=C1 CROPXVXORWPZNY-UHFFFAOYSA-N 0.000 claims 1
- QEZIHYWUMALOMZ-UHFFFAOYSA-N n-(3-phenylpropyl)-6-pyrazol-1-yl-2-thiophen-2-ylpyrimidin-4-amine Chemical compound C=1C=CC=CC=1CCCNC(N=1)=CC(N2N=CC=C2)=NC=1C1=CC=CS1 QEZIHYWUMALOMZ-UHFFFAOYSA-N 0.000 claims 1
- HCFYXRVZUMXIGG-UHFFFAOYSA-N n-(5-methoxy-2-methylphenyl)-2,6-dipyridin-2-ylpyrimidin-4-amine Chemical compound COC1=CC=C(C)C(NC=2N=C(N=C(C=2)C=2N=CC=CC=2)C=2N=CC=CC=2)=C1 HCFYXRVZUMXIGG-UHFFFAOYSA-N 0.000 claims 1
- LCGLVIDOIMLUSI-UHFFFAOYSA-N n-(6-pyrazol-1-yl-2-pyridin-3-ylpyrimidin-4-yl)acetamide Chemical compound N=1C(NC(=O)C)=CC(N2N=CC=C2)=NC=1C1=CC=CN=C1 LCGLVIDOIMLUSI-UHFFFAOYSA-N 0.000 claims 1
- SNKRYDRUEFBYCC-UHFFFAOYSA-N n-(6-pyrazol-1-yl-2-pyridin-3-ylpyrimidin-4-yl)propanamide Chemical compound N=1C(NC(=O)CC)=CC(N2N=CC=C2)=NC=1C1=CC=CN=C1 SNKRYDRUEFBYCC-UHFFFAOYSA-N 0.000 claims 1
- QPQJUOJIJVCOJX-UHFFFAOYSA-N n-(6-pyrazol-1-yl-2-thiophen-2-ylpyrimidin-4-yl)-2-pyridin-3-ylacetamide Chemical compound C=1C(N2N=CC=C2)=NC(C=2SC=CC=2)=NC=1NC(=O)CC1=CC=CN=C1 QPQJUOJIJVCOJX-UHFFFAOYSA-N 0.000 claims 1
- VOFAKEOWCBUZPD-UHFFFAOYSA-N n-(6-pyrazol-1-yl-2-thiophen-2-ylpyrimidin-4-yl)-3-pyridin-3-ylpropanamide Chemical compound C=1C(N2N=CC=C2)=NC(C=2SC=CC=2)=NC=1NC(=O)CCC1=CC=CN=C1 VOFAKEOWCBUZPD-UHFFFAOYSA-N 0.000 claims 1
- AJZQMCSSEHXNFN-UHFFFAOYSA-N n-(6-pyrazol-1-yl-2-thiophen-2-ylpyrimidin-4-yl)acetamide Chemical compound N=1C(NC(=O)C)=CC(N2N=CC=C2)=NC=1C1=CC=CS1 AJZQMCSSEHXNFN-UHFFFAOYSA-N 0.000 claims 1
- QMYHSDLPOQOPTF-UHFFFAOYSA-N n-(6-pyrazol-1-yl-2-thiophen-2-ylpyrimidin-4-yl)propanamide Chemical compound N=1C(NC(=O)CC)=CC(N2N=CC=C2)=NC=1C1=CC=CS1 QMYHSDLPOQOPTF-UHFFFAOYSA-N 0.000 claims 1
- SOUFLPXFOZGNOH-UHFFFAOYSA-N n-(cyclopropylmethyl)-2-(furan-2-yl)-6-(1,3-thiazol-2-yl)pyrimidin-4-amine Chemical compound C1CC1CNC(N=1)=CC(C=2SC=CN=2)=NC=1C1=CC=CO1 SOUFLPXFOZGNOH-UHFFFAOYSA-N 0.000 claims 1
- UUJZCMNTEDSGAB-UHFFFAOYSA-N n-(cyclopropylmethyl)-2-(furan-2-yl)-6-pyrazol-1-ylpyrimidin-4-amine Chemical compound C1CC1CNC(N=1)=CC(N2N=CC=C2)=NC=1C1=CC=CO1 UUJZCMNTEDSGAB-UHFFFAOYSA-N 0.000 claims 1
- XGDJTBDQULGDEC-UHFFFAOYSA-N n-(cyclopropylmethyl)-6-(furan-2-yl)-2-(1,3-thiazol-2-yl)pyrimidin-4-amine Chemical compound C1CC1CNC(N=1)=CC(C=2OC=CC=2)=NC=1C1=NC=CS1 XGDJTBDQULGDEC-UHFFFAOYSA-N 0.000 claims 1
- XKOBRGBDMIRSKE-UHFFFAOYSA-N n-(cyclopropylmethyl)-6-pyrazol-1-yl-2-thiophen-2-ylpyrimidin-4-amine Chemical compound C1CC1CNC(N=1)=CC(N2N=CC=C2)=NC=1C1=CC=CS1 XKOBRGBDMIRSKE-UHFFFAOYSA-N 0.000 claims 1
- LQTOBYUDFCPCOZ-UHFFFAOYSA-N n-[2-(3,4-dimethoxyphenyl)ethyl]-2-(furan-2-yl)-6-(1,3-thiazol-2-yl)pyrimidin-4-amine Chemical compound C1=C(OC)C(OC)=CC=C1CCNC1=CC(C=2SC=CN=2)=NC(C=2OC=CC=2)=N1 LQTOBYUDFCPCOZ-UHFFFAOYSA-N 0.000 claims 1
- SQWZPBMCOJICSV-UHFFFAOYSA-N n-[2-(3,4-dimethoxyphenyl)ethyl]-2-(furan-2-yl)-6-pyrazol-1-ylpyrimidin-4-amine Chemical compound C1=C(OC)C(OC)=CC=C1CCNC1=CC(N2N=CC=C2)=NC(C=2OC=CC=2)=N1 SQWZPBMCOJICSV-UHFFFAOYSA-N 0.000 claims 1
- XSDXKFWXQFNPAQ-UHFFFAOYSA-N n-[2-(3,4-dimethoxyphenyl)ethyl]-6-(furan-2-yl)-2-(1,3-thiazol-2-yl)pyrimidin-4-amine Chemical compound C1=C(OC)C(OC)=CC=C1CCNC1=CC(C=2OC=CC=2)=NC(C=2SC=CN=2)=N1 XSDXKFWXQFNPAQ-UHFFFAOYSA-N 0.000 claims 1
- KWLHIFDDAYLTJB-UHFFFAOYSA-N n-[2-(3,4-dimethoxyphenyl)ethyl]-6-pyrazol-1-yl-2-thiophen-2-ylpyrimidin-4-amine Chemical compound C1=C(OC)C(OC)=CC=C1CCNC1=CC(N2N=CC=C2)=NC(C=2SC=CC=2)=N1 KWLHIFDDAYLTJB-UHFFFAOYSA-N 0.000 claims 1
- CSMMFFIBXRKOCY-UHFFFAOYSA-N n-[2-(3,5-dimethylpyrazol-1-yl)-6-pyridin-2-ylpyrimidin-4-yl]propanamide Chemical compound N=1C(NC(=O)CC)=CC(C=2N=CC=CC=2)=NC=1N1N=C(C)C=C1C CSMMFFIBXRKOCY-UHFFFAOYSA-N 0.000 claims 1
- BORCTAKXHSJRFO-UHFFFAOYSA-N n-[2-(3,5-dimethylpyrazol-1-yl)-6-pyridin-3-ylpyrimidin-4-yl]propanamide Chemical compound N=1C(NC(=O)CC)=CC(C=2C=NC=CC=2)=NC=1N1N=C(C)C=C1C BORCTAKXHSJRFO-UHFFFAOYSA-N 0.000 claims 1
- GKSZAWSCADAMMM-UHFFFAOYSA-N n-[2-(3-methylpyridin-2-yl)-6-pyrazol-1-ylpyrimidin-4-yl]propanamide Chemical compound N=1C(NC(=O)CC)=CC(N2N=CC=C2)=NC=1C1=NC=CC=C1C GKSZAWSCADAMMM-UHFFFAOYSA-N 0.000 claims 1
- KEXBMYBHZAYACB-UHFFFAOYSA-N n-[2-(3-methylthiophen-2-yl)-6-pyrazol-1-ylpyrimidin-4-yl]propanamide Chemical compound N=1C(NC(=O)CC)=CC(N2N=CC=C2)=NC=1C=1SC=CC=1C KEXBMYBHZAYACB-UHFFFAOYSA-N 0.000 claims 1
- SMILIUDJTYZOEI-UHFFFAOYSA-N n-[2-(4-methoxyphenyl)ethyl]-6-pyrazol-1-yl-2-thiophen-2-ylpyrimidin-4-amine Chemical compound C1=CC(OC)=CC=C1CCNC1=CC(N2N=CC=C2)=NC(C=2SC=CC=2)=N1 SMILIUDJTYZOEI-UHFFFAOYSA-N 0.000 claims 1
- RKRUFDRLWAOARG-UHFFFAOYSA-N n-[2-(5-bromofuran-2-yl)-6-pyrazol-1-ylpyrimidin-4-yl]propanamide Chemical compound N=1C(NC(=O)CC)=CC(N2N=CC=C2)=NC=1C1=CC=C(Br)O1 RKRUFDRLWAOARG-UHFFFAOYSA-N 0.000 claims 1
- JPCHKXMBTIAUQP-UHFFFAOYSA-N n-[2-(5-chlorofuran-2-yl)-6-pyrazol-1-ylpyrimidin-4-yl]propanamide Chemical compound N=1C(NC(=O)CC)=CC(N2N=CC=C2)=NC=1C1=CC=C(Cl)O1 JPCHKXMBTIAUQP-UHFFFAOYSA-N 0.000 claims 1
- HNOFBTJKLJHYSO-UHFFFAOYSA-N n-[2-(5-methylfuran-2-yl)-6-(1,3-thiazol-2-yl)pyrimidin-4-yl]-2-pyridin-3-ylpropanamide Chemical compound C=1C=CN=CC=1C(C)C(=O)NC(N=1)=CC(C=2SC=CN=2)=NC=1C1=CC=C(C)O1 HNOFBTJKLJHYSO-UHFFFAOYSA-N 0.000 claims 1
- GGYFMKSUQKVZFI-UHFFFAOYSA-N n-[2-(5-methylfuran-2-yl)-6-pyrazol-1-ylpyrimidin-4-yl]propanamide Chemical compound N=1C(NC(=O)CC)=CC(N2N=CC=C2)=NC=1C1=CC=C(C)O1 GGYFMKSUQKVZFI-UHFFFAOYSA-N 0.000 claims 1
- BQRKUZAQZXGUBJ-UHFFFAOYSA-N n-[2-(furan-2-yl)-6-(1,2,4-triazol-1-yl)pyrimidin-4-yl]acetamide Chemical compound N=1C(NC(=O)C)=CC(N2N=CN=C2)=NC=1C1=CC=CO1 BQRKUZAQZXGUBJ-UHFFFAOYSA-N 0.000 claims 1
- GPGZWKBOOHEKAL-UHFFFAOYSA-N n-[2-(furan-2-yl)-6-(1,2,4-triazol-1-yl)pyrimidin-4-yl]propanamide Chemical compound N=1C(NC(=O)CC)=CC(N2N=CN=C2)=NC=1C1=CC=CO1 GPGZWKBOOHEKAL-UHFFFAOYSA-N 0.000 claims 1
- ASJNGDLSIQTHQV-UHFFFAOYSA-N n-[2-(furan-2-yl)-6-(1,3-thiazol-2-yl)pyrimidin-4-yl]propanamide Chemical compound N=1C(NC(=O)CC)=CC(C=2SC=CN=2)=NC=1C1=CC=CO1 ASJNGDLSIQTHQV-UHFFFAOYSA-N 0.000 claims 1
- OIAFBNDULRTHRL-UHFFFAOYSA-N n-[2-(furan-2-yl)-6-(3-methylpyrazol-1-yl)pyrimidin-4-yl]propanamide Chemical compound N=1C(NC(=O)CC)=CC(N2N=C(C)C=C2)=NC=1C1=CC=CO1 OIAFBNDULRTHRL-UHFFFAOYSA-N 0.000 claims 1
- OCKWMNKEWPYWIV-UHFFFAOYSA-N n-[2-(furan-2-yl)-6-(4-methylpyrazol-1-yl)pyrimidin-4-yl]propanamide Chemical compound N=1C(NC(=O)CC)=CC(N2N=CC(C)=C2)=NC=1C1=CC=CO1 OCKWMNKEWPYWIV-UHFFFAOYSA-N 0.000 claims 1
- FFUVKDSZKVJNLN-UHFFFAOYSA-N n-[2-(furan-2-yl)-6-(triazol-1-yl)pyrimidin-4-yl]propanamide Chemical compound N=1C(NC(=O)CC)=CC(N2N=NC=C2)=NC=1C1=CC=CO1 FFUVKDSZKVJNLN-UHFFFAOYSA-N 0.000 claims 1
- GLFWCNZHECBNED-UHFFFAOYSA-N n-[2-(furan-2-yl)-6-(triazol-2-yl)pyrimidin-4-yl]propanamide Chemical compound N=1C(NC(=O)CC)=CC(N2N=CC=N2)=NC=1C1=CC=CO1 GLFWCNZHECBNED-UHFFFAOYSA-N 0.000 claims 1
- GDBRDHCVYPGWEI-UHFFFAOYSA-N n-[2-(furan-2-yl)-6-[5-methyl-3-(trifluoromethyl)pyrazol-1-yl]pyrimidin-4-yl]propanamide Chemical compound N=1C(NC(=O)CC)=CC(N2C(=CC(=N2)C(F)(F)F)C)=NC=1C1=CC=CO1 GDBRDHCVYPGWEI-UHFFFAOYSA-N 0.000 claims 1
- HRRWXOMEPPUOTB-UHFFFAOYSA-N n-[2-(furan-2-yl)-6-pyrazol-1-ylpyrimidin-4-yl]-2,2-dimethylpropanamide Chemical compound N=1C(NC(=O)C(C)(C)C)=CC(N2N=CC=C2)=NC=1C1=CC=CO1 HRRWXOMEPPUOTB-UHFFFAOYSA-N 0.000 claims 1
- WQKOCIAPBZTFSU-UHFFFAOYSA-N n-[2-(furan-2-yl)-6-pyrazol-1-ylpyrimidin-4-yl]-2-(3-methoxyphenyl)acetamide Chemical compound COC1=CC=CC(CC(=O)NC=2N=C(N=C(C=2)N2N=CC=C2)C=2OC=CC=2)=C1 WQKOCIAPBZTFSU-UHFFFAOYSA-N 0.000 claims 1
- HBMVQQKZDVNWDB-UHFFFAOYSA-N n-[2-(furan-2-yl)-6-pyrazol-1-ylpyrimidin-4-yl]-2-(methylamino)acetamide Chemical compound N=1C(NC(=O)CNC)=CC(N2N=CC=C2)=NC=1C1=CC=CO1 HBMVQQKZDVNWDB-UHFFFAOYSA-N 0.000 claims 1
- FASCDAMAJJSUQQ-UHFFFAOYSA-N n-[2-(furan-2-yl)-6-pyrazol-1-ylpyrimidin-4-yl]-2-methyl-3-phenylpropanamide Chemical compound C=1C(N2N=CC=C2)=NC(C=2OC=CC=2)=NC=1NC(=O)C(C)CC1=CC=CC=C1 FASCDAMAJJSUQQ-UHFFFAOYSA-N 0.000 claims 1
- AZWHWJUDIGTIQE-UHFFFAOYSA-N n-[2-(furan-2-yl)-6-pyrazol-1-ylpyrimidin-4-yl]-2-methylpropanamide Chemical compound N=1C(NC(=O)C(C)C)=CC(N2N=CC=C2)=NC=1C1=CC=CO1 AZWHWJUDIGTIQE-UHFFFAOYSA-N 0.000 claims 1
- XNTXVDIXVYTUAT-UHFFFAOYSA-N n-[2-(furan-2-yl)-6-pyrazol-1-ylpyrimidin-4-yl]-2-phenylacetamide Chemical compound C=1C(N2N=CC=C2)=NC(C=2OC=CC=2)=NC=1NC(=O)CC1=CC=CC=C1 XNTXVDIXVYTUAT-UHFFFAOYSA-N 0.000 claims 1
- AJGIMEXPLHYREY-UHFFFAOYSA-N n-[2-(furan-2-yl)-6-pyrazol-1-ylpyrimidin-4-yl]-2-pyridin-3-ylacetamide Chemical compound C=1C(N2N=CC=C2)=NC(C=2OC=CC=2)=NC=1NC(=O)CC1=CC=CN=C1 AJGIMEXPLHYREY-UHFFFAOYSA-N 0.000 claims 1
- MEFGAFZXTADQBN-UHFFFAOYSA-N n-[2-(furan-2-yl)-6-pyrazol-1-ylpyrimidin-4-yl]-3,3-dimethylbutanamide Chemical compound N=1C(NC(=O)CC(C)(C)C)=CC(N2N=CC=C2)=NC=1C1=CC=CO1 MEFGAFZXTADQBN-UHFFFAOYSA-N 0.000 claims 1
- IKWFYZAWDNOZRJ-UHFFFAOYSA-N n-[2-(furan-2-yl)-6-pyrazol-1-ylpyrimidin-4-yl]-3,4-dimethoxybenzamide Chemical compound C1=C(OC)C(OC)=CC=C1C(=O)NC1=CC(N2N=CC=C2)=NC(C=2OC=CC=2)=N1 IKWFYZAWDNOZRJ-UHFFFAOYSA-N 0.000 claims 1
- AEUKPBMDJLWMRZ-UHFFFAOYSA-N n-[2-(furan-2-yl)-6-pyrazol-1-ylpyrimidin-4-yl]-3-methylbutanamide Chemical compound N=1C(NC(=O)CC(C)C)=CC(N2N=CC=C2)=NC=1C1=CC=CO1 AEUKPBMDJLWMRZ-UHFFFAOYSA-N 0.000 claims 1
- LRXCGHGRKLGDDL-UHFFFAOYSA-N n-[2-(furan-2-yl)-6-pyrazol-1-ylpyrimidin-4-yl]-3-phenoxypropanamide Chemical compound C=1C(N2N=CC=C2)=NC(C=2OC=CC=2)=NC=1NC(=O)CCOC1=CC=CC=C1 LRXCGHGRKLGDDL-UHFFFAOYSA-N 0.000 claims 1
- ALQTTZFGYCVGJI-UHFFFAOYSA-N n-[2-(furan-2-yl)-6-pyrazol-1-ylpyrimidin-4-yl]-3-phenylpropanamide Chemical compound C=1C(N2N=CC=C2)=NC(C=2OC=CC=2)=NC=1NC(=O)CCC1=CC=CC=C1 ALQTTZFGYCVGJI-UHFFFAOYSA-N 0.000 claims 1
- RCTPRAVECOPXLI-UHFFFAOYSA-N n-[2-(furan-2-yl)-6-pyrazol-1-ylpyrimidin-4-yl]-3-pyridin-3-ylpropanamide Chemical compound C=1C(N2N=CC=C2)=NC(C=2OC=CC=2)=NC=1NC(=O)CCC1=CC=CN=C1 RCTPRAVECOPXLI-UHFFFAOYSA-N 0.000 claims 1
- YBZHQFAVAQZLFB-UHFFFAOYSA-N n-[2-(furan-2-yl)-6-pyrazol-1-ylpyrimidin-4-yl]acetamide Chemical compound N=1C(NC(=O)C)=CC(N2N=CC=C2)=NC=1C1=CC=CO1 YBZHQFAVAQZLFB-UHFFFAOYSA-N 0.000 claims 1
- XPSJEZACEFWUPJ-UHFFFAOYSA-N n-[2-(furan-2-yl)-6-pyrazol-1-ylpyrimidin-4-yl]benzamide Chemical compound C=1C=CC=CC=1C(=O)NC(N=1)=CC(N2N=CC=C2)=NC=1C1=CC=CO1 XPSJEZACEFWUPJ-UHFFFAOYSA-N 0.000 claims 1
- HNPPVVJHXVDXLZ-UHFFFAOYSA-N n-[2-(furan-2-yl)-6-pyrazol-1-ylpyrimidin-4-yl]cyclobutanecarboxamide Chemical compound C1CCC1C(=O)NC(N=1)=CC(N2N=CC=C2)=NC=1C1=CC=CO1 HNPPVVJHXVDXLZ-UHFFFAOYSA-N 0.000 claims 1
- SIONYAHVIQQTPE-UHFFFAOYSA-N n-[2-(furan-2-yl)-6-pyrazol-1-ylpyrimidin-4-yl]cyclohexanecarboxamide Chemical compound C1CCCCC1C(=O)NC(N=1)=CC(N2N=CC=C2)=NC=1C1=CC=CO1 SIONYAHVIQQTPE-UHFFFAOYSA-N 0.000 claims 1
- SJZNCGSZWVVJNX-UHFFFAOYSA-N n-[2-(furan-2-yl)-6-pyrazol-1-ylpyrimidin-4-yl]cyclopentanecarboxamide Chemical compound C1CCCC1C(=O)NC(N=1)=CC(N2N=CC=C2)=NC=1C1=CC=CO1 SJZNCGSZWVVJNX-UHFFFAOYSA-N 0.000 claims 1
- FIPSYMVOQDSYDE-UHFFFAOYSA-N n-[2-(furan-2-yl)-6-pyrazol-1-ylpyrimidin-4-yl]cyclopropanecarboxamide Chemical compound C1CC1C(=O)NC(N=1)=CC(N2N=CC=C2)=NC=1C1=CC=CO1 FIPSYMVOQDSYDE-UHFFFAOYSA-N 0.000 claims 1
- OFRDMRNKGZPWTF-UHFFFAOYSA-N n-[2-(furan-2-yl)-6-pyrazol-1-ylpyrimidin-4-yl]furan-2-carboxamide Chemical compound C=1C=COC=1C(=O)NC(N=1)=CC(N2N=CC=C2)=NC=1C1=CC=CO1 OFRDMRNKGZPWTF-UHFFFAOYSA-N 0.000 claims 1
- TYFFFWYCYVBKHF-UHFFFAOYSA-N n-[2-(furan-2-yl)-6-pyrazol-1-ylpyrimidin-4-yl]naphthalene-1-carboxamide Chemical compound C=1C=CC2=CC=CC=C2C=1C(=O)NC(N=1)=CC(N2N=CC=C2)=NC=1C1=CC=CO1 TYFFFWYCYVBKHF-UHFFFAOYSA-N 0.000 claims 1
- WADWVLAZRXMGSM-UHFFFAOYSA-N n-[2-(furan-2-yl)-6-pyrazol-1-ylpyrimidin-4-yl]propanamide Chemical compound N=1C(NC(=O)CC)=CC(N2N=CC=C2)=NC=1C1=CC=CO1 WADWVLAZRXMGSM-UHFFFAOYSA-N 0.000 claims 1
- FBCPKDLPHSXPFZ-UHFFFAOYSA-N n-[2-(furan-2-yl)-6-pyrazol-1-ylpyrimidin-4-yl]pyridine-4-carboxamide Chemical compound C=1C=NC=CC=1C(=O)NC(N=1)=CC(N2N=CC=C2)=NC=1C1=CC=CO1 FBCPKDLPHSXPFZ-UHFFFAOYSA-N 0.000 claims 1
- BZVYUHDCOJRKOF-UHFFFAOYSA-N n-[2-(furan-2-yl)-6-pyrazol-1-ylpyrimidin-4-yl]quinoline-2-carboxamide Chemical compound C=1C=C2C=CC=CC2=NC=1C(=O)NC(N=1)=CC(N2N=CC=C2)=NC=1C1=CC=CO1 BZVYUHDCOJRKOF-UHFFFAOYSA-N 0.000 claims 1
- ZHSFVUMTMACOKM-UHFFFAOYSA-N n-[2-(furan-2-yl)-6-pyrazol-1-ylpyrimidin-4-yl]thiophene-2-carboxamide Chemical compound C=1C=CSC=1C(=O)NC(N=1)=CC(N2N=CC=C2)=NC=1C1=CC=CO1 ZHSFVUMTMACOKM-UHFFFAOYSA-N 0.000 claims 1
- RJMRDYQXJDKSKX-UHFFFAOYSA-N n-[2-(furan-2-yl)-6-pyridin-3-ylpyrimidin-4-yl]propanamide Chemical compound N=1C(NC(=O)CC)=CC(C=2C=NC=CC=2)=NC=1C1=CC=CO1 RJMRDYQXJDKSKX-UHFFFAOYSA-N 0.000 claims 1
- XSDVHNZTCVMNPD-UHFFFAOYSA-N n-[2-thiophen-2-yl-6-(1,2,4-triazol-1-yl)pyrimidin-4-yl]acetamide Chemical compound N=1C(NC(=O)C)=CC(N2N=CN=C2)=NC=1C1=CC=CS1 XSDVHNZTCVMNPD-UHFFFAOYSA-N 0.000 claims 1
- VUITWOKXROSNHN-UHFFFAOYSA-N n-[2-thiophen-2-yl-6-(1,2,4-triazol-1-yl)pyrimidin-4-yl]propanamide Chemical compound N=1C(NC(=O)CC)=CC(N2N=CN=C2)=NC=1C1=CC=CS1 VUITWOKXROSNHN-UHFFFAOYSA-N 0.000 claims 1
- INCAXCUFMUPOBY-UHFFFAOYSA-N n-[6-(3,5-dimethylpyrazol-1-yl)-2-(furan-2-yl)pyrimidin-4-yl]-2,2-dimethylpropanamide Chemical compound N1=C(C)C=C(C)N1C1=CC(NC(=O)C(C)(C)C)=NC(C=2OC=CC=2)=N1 INCAXCUFMUPOBY-UHFFFAOYSA-N 0.000 claims 1
- GZVDTCKPRYKALF-UHFFFAOYSA-N n-[6-(3,5-dimethylpyrazol-1-yl)-2-(furan-2-yl)pyrimidin-4-yl]-2-methylpropanamide Chemical compound N=1C(NC(=O)C(C)C)=CC(N2C(=CC(C)=N2)C)=NC=1C1=CC=CO1 GZVDTCKPRYKALF-UHFFFAOYSA-N 0.000 claims 1
- NTMGXPLMPVWMRG-UHFFFAOYSA-N n-[6-(3,5-dimethylpyrazol-1-yl)-2-(furan-2-yl)pyrimidin-4-yl]-2-pyridin-3-ylacetamide Chemical compound N1=C(C)C=C(C)N1C1=CC(NC(=O)CC=2C=NC=CC=2)=NC(C=2OC=CC=2)=N1 NTMGXPLMPVWMRG-UHFFFAOYSA-N 0.000 claims 1
- UQUFSAWVNAXBLX-UHFFFAOYSA-N n-[6-(3,5-dimethylpyrazol-1-yl)-2-(furan-2-yl)pyrimidin-4-yl]-3,3,3-trifluoropropanamide Chemical compound N1=C(C)C=C(C)N1C1=CC(NC(=O)CC(F)(F)F)=NC(C=2OC=CC=2)=N1 UQUFSAWVNAXBLX-UHFFFAOYSA-N 0.000 claims 1
- JXLMWWSWIJCZNF-UHFFFAOYSA-N n-[6-(3,5-dimethylpyrazol-1-yl)-2-(furan-2-yl)pyrimidin-4-yl]-3-phenoxypropanamide Chemical compound N1=C(C)C=C(C)N1C1=CC(NC(=O)CCOC=2C=CC=CC=2)=NC(C=2OC=CC=2)=N1 JXLMWWSWIJCZNF-UHFFFAOYSA-N 0.000 claims 1
- NFHCOXMRCXSCKS-UHFFFAOYSA-N n-[6-(3,5-dimethylpyrazol-1-yl)-2-(furan-2-yl)pyrimidin-4-yl]-3-phenylpropanamide Chemical compound N1=C(C)C=C(C)N1C1=CC(NC(=O)CCC=2C=CC=CC=2)=NC(C=2OC=CC=2)=N1 NFHCOXMRCXSCKS-UHFFFAOYSA-N 0.000 claims 1
- XLOFDDHIHSHUQD-UHFFFAOYSA-N n-[6-(3,5-dimethylpyrazol-1-yl)-2-(furan-2-yl)pyrimidin-4-yl]-3-pyridin-3-ylpropanamide Chemical compound N1=C(C)C=C(C)N1C1=CC(NC(=O)CCC=2C=NC=CC=2)=NC(C=2OC=CC=2)=N1 XLOFDDHIHSHUQD-UHFFFAOYSA-N 0.000 claims 1
- HJCXANDYHPXHPE-UHFFFAOYSA-N n-[6-(3,5-dimethylpyrazol-1-yl)-2-(furan-2-yl)pyrimidin-4-yl]acetamide Chemical compound N=1C(NC(=O)C)=CC(N2C(=CC(C)=N2)C)=NC=1C1=CC=CO1 HJCXANDYHPXHPE-UHFFFAOYSA-N 0.000 claims 1
- PPPMGFCJKNMKHL-UHFFFAOYSA-N n-[6-(3,5-dimethylpyrazol-1-yl)-2-(furan-2-yl)pyrimidin-4-yl]cyclopropanecarboxamide Chemical compound N1=C(C)C=C(C)N1C1=CC(NC(=O)C2CC2)=NC(C=2OC=CC=2)=N1 PPPMGFCJKNMKHL-UHFFFAOYSA-N 0.000 claims 1
- KXAGWGBQJVNEOM-UHFFFAOYSA-N n-[6-(3,5-dimethylpyrazol-1-yl)-2-pyridin-3-ylpyrimidin-4-yl]-3,3,3-trifluoropropanamide Chemical compound N1=C(C)C=C(C)N1C1=CC(NC(=O)CC(F)(F)F)=NC(C=2C=NC=CC=2)=N1 KXAGWGBQJVNEOM-UHFFFAOYSA-N 0.000 claims 1
- BXYFEBTYDGHXGR-UHFFFAOYSA-N n-[6-(3,5-dimethylpyrazol-1-yl)-2-pyridin-3-ylpyrimidin-4-yl]acetamide Chemical compound N=1C(NC(=O)C)=CC(N2C(=CC(C)=N2)C)=NC=1C1=CC=CN=C1 BXYFEBTYDGHXGR-UHFFFAOYSA-N 0.000 claims 1
- BWMYKWBYZULDGH-UHFFFAOYSA-N n-[6-(3,5-dimethylpyrazol-1-yl)-2-pyridin-3-ylpyrimidin-4-yl]propanamide Chemical compound N=1C(NC(=O)CC)=CC(N2C(=CC(C)=N2)C)=NC=1C1=CC=CN=C1 BWMYKWBYZULDGH-UHFFFAOYSA-N 0.000 claims 1
- JPBSCOOFPMTQGQ-UHFFFAOYSA-N n-[6-(3,5-dimethylpyrazol-1-yl)-2-pyridin-4-ylpyrimidin-4-yl]propanamide Chemical compound N=1C(NC(=O)CC)=CC(N2C(=CC(C)=N2)C)=NC=1C1=CC=NC=C1 JPBSCOOFPMTQGQ-UHFFFAOYSA-N 0.000 claims 1
- MKZGAUPNHOBBOF-UHFFFAOYSA-N n-[6-(3,5-dimethylpyrazol-1-yl)-2-thiophen-2-ylpyrimidin-4-yl]-3,3,3-trifluoropropanamide Chemical compound N1=C(C)C=C(C)N1C1=CC(NC(=O)CC(F)(F)F)=NC(C=2SC=CC=2)=N1 MKZGAUPNHOBBOF-UHFFFAOYSA-N 0.000 claims 1
- ZEMFJEXJRQASDU-UHFFFAOYSA-N n-[6-(3,5-dimethylpyrazol-1-yl)-2-thiophen-2-ylpyrimidin-4-yl]acetamide Chemical compound N=1C(NC(=O)C)=CC(N2C(=CC(C)=N2)C)=NC=1C1=CC=CS1 ZEMFJEXJRQASDU-UHFFFAOYSA-N 0.000 claims 1
- RWNFSLNKDDRHGX-UHFFFAOYSA-N n-[6-(3,5-dimethylpyrazol-1-yl)-2-thiophen-2-ylpyrimidin-4-yl]propanamide Chemical compound N=1C(NC(=O)CC)=CC(N2C(=CC(C)=N2)C)=NC=1C1=CC=CS1 RWNFSLNKDDRHGX-UHFFFAOYSA-N 0.000 claims 1
- LGJDLQMOQOKNAH-UHFFFAOYSA-N n-[6-(furan-2-yl)-2-(1,2,4-triazol-1-yl)pyrimidin-4-yl]propanamide Chemical compound N=1C(NC(=O)CC)=CC(C=2OC=CC=2)=NC=1N1C=NC=N1 LGJDLQMOQOKNAH-UHFFFAOYSA-N 0.000 claims 1
- GBVUFRZOUFCMOA-UHFFFAOYSA-N n-[6-(furan-2-yl)-2-(1,3-thiazol-2-yl)pyrimidin-4-yl]propanamide Chemical compound N=1C(NC(=O)CC)=CC(C=2OC=CC=2)=NC=1C1=NC=CS1 GBVUFRZOUFCMOA-UHFFFAOYSA-N 0.000 claims 1
- GUYUWLWPPRCSEQ-UHFFFAOYSA-N n-[6-(furan-2-yl)-2-pyrazol-1-ylpyrimidin-4-yl]acetamide Chemical compound N=1C(NC(=O)C)=CC(C=2OC=CC=2)=NC=1N1C=CC=N1 GUYUWLWPPRCSEQ-UHFFFAOYSA-N 0.000 claims 1
- XLSVZEUWQMAFPT-UHFFFAOYSA-N n-[6-(furan-2-yl)-2-pyrazol-1-ylpyrimidin-4-yl]propanamide Chemical compound N=1C(NC(=O)CC)=CC(C=2OC=CC=2)=NC=1N1C=CC=N1 XLSVZEUWQMAFPT-UHFFFAOYSA-N 0.000 claims 1
- FFAIDQSQRXJUGE-UHFFFAOYSA-N n-[6-(furan-2-yl)-2-pyridin-2-ylpyrimidin-4-yl]propanamide Chemical compound N=1C(NC(=O)CC)=CC(C=2OC=CC=2)=NC=1C1=CC=CC=N1 FFAIDQSQRXJUGE-UHFFFAOYSA-N 0.000 claims 1
- UWGCWEVHSKPOJW-UHFFFAOYSA-N n-[6-(furan-2-yl)-2-pyridin-3-ylpyrimidin-4-yl]propanamide Chemical compound N=1C(NC(=O)CC)=CC(C=2OC=CC=2)=NC=1C1=CC=CN=C1 UWGCWEVHSKPOJW-UHFFFAOYSA-N 0.000 claims 1
- IOYVPMWXWATMGA-UHFFFAOYSA-N n-[6-(furan-2-yl)-2-pyridin-4-ylpyrimidin-4-yl]propanamide Chemical compound N=1C(NC(=O)CC)=CC(C=2OC=CC=2)=NC=1C1=CC=NC=C1 IOYVPMWXWATMGA-UHFFFAOYSA-N 0.000 claims 1
- 229960003966 nicotinamide Drugs 0.000 claims 1
- 235000005152 nicotinamide Nutrition 0.000 claims 1
- 239000011570 nicotinamide Substances 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 125000005359 phenoxyalkyl group Chemical group 0.000 claims 1
- 125000003884 phenylalkyl group Chemical group 0.000 claims 1
- QLNJFJADRCOGBJ-UHFFFAOYSA-N propionamide Chemical compound CCC(N)=O QLNJFJADRCOGBJ-UHFFFAOYSA-N 0.000 claims 1
- 229940080818 propionamide Drugs 0.000 claims 1
- 150000003217 pyrazoles Chemical class 0.000 claims 1
- 102000005962 receptors Human genes 0.000 claims 1
- 108020003175 receptors Proteins 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 229920006395 saturated elastomer Polymers 0.000 claims 1
- 125000003107 substituted aryl group Chemical group 0.000 claims 1
- 150000003557 thiazoles Chemical class 0.000 claims 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ESP200302951 | 2003-12-15 | ||
| ES200302951A ES2234433B1 (es) | 2003-12-15 | 2003-12-15 | 4-aminopirimidinas como antagonistas de receptores de adenosina. |
| EPPCT/EP2004/011086 | 2004-10-05 | ||
| EP2004011086 | 2004-10-05 | ||
| PCT/US2004/041970 WO2005058883A1 (en) | 2003-12-15 | 2004-12-14 | 2, 6 bisheteroaryl-4-aminopyrimidines as adenosine receptor antagonists |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2007514003A JP2007514003A (ja) | 2007-05-31 |
| JP2007514003A6 JP2007514003A6 (ja) | 2007-09-06 |
| JP2007514003A5 true JP2007514003A5 (https=) | 2008-01-17 |
Family
ID=34702454
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006545817A Pending JP2007514003A (ja) | 2003-12-15 | 2004-12-14 | アデノシン受容体アンタゴニストとしての２，６−ビスヘテロアリール−４−アミノピリミジン |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20080058356A1 (https=) |
| JP (1) | JP2007514003A (https=) |
| AU (1) | AU2004299461A1 (https=) |
| BR (1) | BRPI0417478A (https=) |
| CA (1) | CA2551944A1 (https=) |
| EA (1) | EA010568B1 (https=) |
| IL (1) | IL176005A0 (https=) |
| MX (1) | MXPA06006776A (https=) |
| NO (1) | NO20062713L (https=) |
| SM (1) | SMP200600024B (https=) |
| UA (1) | UA83101C2 (https=) |
| WO (1) | WO2005058883A1 (https=) |
Families Citing this family (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0323137D0 (en) | 2003-10-03 | 2003-11-05 | Chang Lisa C W | 2,4,6- Trisubstituted pyrimidines and their different uses |
| GB0403635D0 (en) * | 2004-02-18 | 2004-03-24 | Devgen Nv | Pyridinocarboxamides with improved activity as kinase inhibitors |
| DE602006020864D1 (de) * | 2005-04-11 | 2011-05-05 | Almirall Sa | 2, 6-di-(hetero-)aryl-4-amido-pyrimidine als adenosin-rezeptor-antagonisten |
| ES2273599B1 (es) | 2005-10-14 | 2008-06-01 | Universidad De Barcelona | Compuestos para el tratamiento de la fibrilacion auricular. |
| EP1976851A2 (en) * | 2006-01-17 | 2008-10-08 | Neurocrine Biosciences, Inc. | Phenoxy-substituted pyrimidines as adenosine receptor antagonists |
| PL2044056T3 (pl) | 2006-07-14 | 2013-01-31 | Novartis Ag | Pochodne pirymidyny jako inhibitory ALK-5 |
| EP2079728B1 (en) | 2006-10-10 | 2013-09-25 | Amgen Inc. | N-aryl pyrazole compounds for use against diabetes |
| JP2010511727A (ja) * | 2006-12-04 | 2010-04-15 | ニューロクライン バイオサイエンシーズ，インコーポレイテッド | アデノシン受容体アンタゴニストとしての置換ピリミジン |
| CA2672494A1 (en) | 2006-12-14 | 2008-06-19 | Nps Pharmaceuticals, Inc. | Use of d-serine derivatives for the treatment of anxiety disorders |
| WO2008116185A2 (en) * | 2007-03-21 | 2008-09-25 | Neurocrine Biosciences, Inc. | Substituted pyrimidines as adenosine receptor antagonists |
| WO2008128984A1 (en) * | 2007-04-20 | 2008-10-30 | Probiodrug Ag | Aminopyrimidine derivatives as glutaminyl cyclase inhibitors |
| CN101903385B (zh) * | 2007-12-21 | 2013-11-06 | 帕劳制药股份有限公司 | 作为组胺h4受体拮抗剂的4-氨基嘧啶衍生物 |
| WO2010043721A1 (en) | 2008-10-17 | 2010-04-22 | Oryzon Genomics, S.A. | Oxidase inhibitors and their use |
| US8993808B2 (en) | 2009-01-21 | 2015-03-31 | Oryzon Genomics, S.A. | Phenylcyclopropylamine derivatives and their medical use |
| MX2011012343A (es) * | 2009-05-19 | 2011-12-14 | Dow Agrosciences Llc | Compuestos y metodos para controlar hongos. |
| US8859555B2 (en) | 2009-09-25 | 2014-10-14 | Oryzon Genomics S.A. | Lysine Specific Demethylase-1 inhibitors and their use |
| EP2486002B1 (en) | 2009-10-09 | 2019-03-27 | Oryzon Genomics, S.A. | Substituted heteroaryl- and aryl- cyclopropylamine acetamides and their use |
| WO2011106574A2 (en) | 2010-02-24 | 2011-09-01 | Oryzon Genomics, S.A. | Inhibitors for antiviral use |
| WO2011106106A2 (en) | 2010-02-24 | 2011-09-01 | Oryzon Genomics, S.A. | Lysine demethylase inhibitors for diseases and disorders associated with hepadnaviridae |
| ES2365960B1 (es) * | 2010-03-31 | 2012-06-04 | Palobiofarma, S.L | Nuevos antagonistas de los receptores de adenosina. |
| CA2796726C (en) | 2010-04-19 | 2021-02-16 | Oryzon Genomics S.A. | Lysine specific demethylase-1 inhibitors and their use |
| BR112013002164B1 (pt) | 2010-07-29 | 2021-11-09 | Oryzon Genomics S.A. | Inibidores de desmetilase à base de arilciclopropilamina de lsd1, seus usos, e composição farmacêutica |
| US9006449B2 (en) | 2010-07-29 | 2015-04-14 | Oryzon Genomics, S.A. | Cyclopropylamine derivatives useful as LSD1 inhibitors |
| JP6245983B2 (ja) | 2010-08-11 | 2017-12-13 | ドレクセル ユニバーシティ | パーキンソン病におけるジスキネジアを治療するための新規ｄ３ドーパミン受容体アゴニスト |
| US9061966B2 (en) | 2010-10-08 | 2015-06-23 | Oryzon Genomics S.A. | Cyclopropylamine inhibitors of oxidases |
| WO2012072713A2 (en) | 2010-11-30 | 2012-06-07 | Oryzon Genomics, S.A. | Lysine demethylase inhibitors for diseases and disorders associated with flaviviridae |
| EP2712315B1 (en) | 2011-02-08 | 2021-11-24 | Oryzon Genomics, S.A. | Lysine demethylase inhibitors for myeloproliferative disorders |
| US20140329833A1 (en) * | 2011-05-19 | 2014-11-06 | Oryzon Genomics, S.A | Lysine demethylase inhibitors for inflammatory diseases or conditions |
| WO2013052526A1 (en) * | 2011-10-06 | 2013-04-11 | Merck Sharp & Dohme Corp. | Triazolyl pde10 inhibitors |
| JP6046154B2 (ja) | 2011-10-20 | 2016-12-14 | オリソン ヘノミクス エセ． アー． | Ｌｓｄ１阻害剤としての（ヘテロ）アリールシクロプロピルアミン化合物 |
| EP2768805B1 (en) | 2011-10-20 | 2020-03-25 | Oryzon Genomics, S.A. | (hetero)aryl cyclopropylamine compounds as lsd1 inhibitors |
| PL3062791T3 (pl) | 2013-10-28 | 2020-06-15 | Drexel University | Nowoczesne terapie zaburzeń uwagi i zaburzeń poznawczych oraz otępienia związanych z zaburzeniem neurodegeneracyjnym |
| AU2016258192B2 (en) | 2015-05-06 | 2021-07-29 | Leidos Biomedical Research, Inc. | K-Ras modulators |
| MX373318B (es) | 2015-08-11 | 2020-05-21 | Novartis Ag | 5-bromo-2,6-di-(1h-pirazol-1-il) pirimidin-4-amina-para su uso en el tratamiento del cáncer. |
| HUE064141T2 (hu) | 2017-01-20 | 2024-02-28 | Arcus Biosciences Inc | Azolopirimidin rákkal összefüggõ rendellenességek kezelésére |
| EP3612526A2 (en) * | 2017-04-20 | 2020-02-26 | The Regents of the University of California | K-ras modulators |
| ES2953349T3 (es) * | 2017-05-05 | 2023-11-10 | Arcus Biosciences Inc | Derivados de quinazolina-piridina para el tratamiento de trastornos relacionados con el cáncer |
| JP7273732B2 (ja) | 2017-05-31 | 2023-05-15 | ノバルティス アーゲー | ５－ブロモ－２，６－ジ（１ｈ－ピラゾール－１－イル）ピリミジン－４－アミン及び新たな塩の結晶形 |
| CA3090922A1 (en) | 2018-02-16 | 2019-08-22 | Arcus Biosciences, Inc. | Dosing with an azolopyrimidine compound |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4725600A (en) * | 1984-07-13 | 1988-02-16 | Fujisawa Pharmaceutical Co., Ltd. | Pyrimidine compounds having activity as a cardiotonic anti-hypertensive cerebrovascular vasodilator and anti-platelet aggregation agent |
| DE3905364A1 (de) * | 1989-02-22 | 1990-08-23 | Hoechst Ag | Substituierte pyrimidin-derivate, verfahren zu ihrer herstellung und ihre verwendung als tool |
| DE19710435A1 (de) * | 1997-03-13 | 1998-09-17 | Hoechst Ag | Verwendung von Pyrimidinderivaten zur Prävention von Krebs allein oder in Kombination mit anderen therapeutischen Maßnahmen |
| JPH11158073A (ja) * | 1997-09-26 | 1999-06-15 | Takeda Chem Ind Ltd | アデノシンａ３拮抗剤 |
| DE19836697A1 (de) * | 1998-08-13 | 2000-02-17 | Hoechst Marion Roussel De Gmbh | Substituierte 4-Amino-2-aryl-pyrimidine, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate |
| AU1522400A (en) * | 1998-11-12 | 2000-05-29 | Elan Pharmaceuticals, Inc. | Substituted pyrimidine compositions and methods of use |
| WO2001062233A2 (en) | 2000-02-25 | 2001-08-30 | F. Hoffmann La Roche Ag | Adenosine receptor modulators |
| AU5260601A (en) * | 2000-04-26 | 2001-11-07 | Eisai Co Ltd | Medicinal compositions promoting bowel movement |
| JP4272338B2 (ja) * | 2000-09-22 | 2009-06-03 | バイエル アクチェンゲゼルシャフト | ピリジン誘導体 |
| EP1351691A4 (en) * | 2000-12-12 | 2005-06-22 | Cytovia Inc | SUBSTITUTED 2-ARYL-4-ARYLAMINOPYRIMIDINES AND ANALOGUES AS ACTIVATORS OF CASPASES AND APOPTOSIS INDUCERS, AND USE THEREOF |
| US6716851B2 (en) * | 2000-12-12 | 2004-04-06 | Cytovia, Inc. | Substituted 2-aryl-4-arylaminopyrimidines and analogs as activators or caspases and inducers of apoptosis and the use thereof |
| US20030078271A1 (en) * | 2001-01-31 | 2003-04-24 | Blackburn Thomas P. | Use of GAL3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods |
| US7024532B2 (en) | 2001-08-09 | 2006-04-04 | Matsushita Electric Industrial Co., Ltd. | File management method, and memory card and terminal apparatus that make use of the method |
| TWI330183B (https=) * | 2001-10-22 | 2010-09-11 | Eisai R&D Man Co Ltd | |
| WO2005047279A1 (en) * | 2003-11-10 | 2005-05-26 | Merck Sharp & Dohme Limited | Substituted nitrogen-containing six-membered amino-heterocycles as vanilloid-1 receptor antagonists for treating pain |
-
2004
- 2004-12-14 CA CA002551944A patent/CA2551944A1/en not_active Abandoned
- 2004-12-14 BR BRPI0417478-0A patent/BRPI0417478A/pt not_active Application Discontinuation
- 2004-12-14 US US10/582,704 patent/US20080058356A1/en not_active Abandoned
- 2004-12-14 JP JP2006545817A patent/JP2007514003A/ja active Pending
- 2004-12-14 UA UAA200607870A patent/UA83101C2/ru unknown
- 2004-12-14 MX MXPA06006776A patent/MXPA06006776A/es active IP Right Grant
- 2004-12-14 EA EA200601160A patent/EA010568B1/ru not_active IP Right Cessation
- 2004-12-14 AU AU2004299461A patent/AU2004299461A1/en not_active Abandoned
- 2004-12-14 WO PCT/US2004/041970 patent/WO2005058883A1/en not_active Ceased
- 2004-12-14 SM SM200600024T patent/SMP200600024B/it unknown
-
2006
- 2006-05-30 IL IL176005A patent/IL176005A0/en unknown
- 2006-06-12 NO NO20062713A patent/NO20062713L/no not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007514003A5 (https=) | ||
| JP2005532982A5 (https=) | ||
| JP2005524668A5 (https=) | ||
| JP5127402B2 (ja) | ヒストンデアセチラーゼの阻害剤 | |
| US7105567B2 (en) | 3-substituted urea derivatives and medicinal use thereof | |
| JP2014508128A5 (https=) | ||
| RU2006145205A (ru) | Терапевтические соединения: пиридин в качестве каркаса | |
| JP2008500336A5 (https=) | ||
| JP2016523923A5 (https=) | ||
| AU2004299461A1 (en) | 2, 6 bisheteroaryl-4-aminopyrimidines as adenosine receptor antagonists | |
| RU2019136279A (ru) | C5 -Анилинохиназолиновые соединения и их использование в лечении рака | |
| JP2004525951A5 (https=) | ||
| MXPA05010475A (es) | Novedosos derivados de quinolina, tetrahidroquinazolina, y pirimida y metodos para tratamiento relacionados con su uso. | |
| JP2013507350A5 (https=) | ||
| JP2007519754A5 (https=) | ||
| JP2005522438A5 (https=) | ||
| RU2011149360A (ru) | Замещенные фенилмочевины и фениламиды в качестве лигандов ваниллоидных рецепторов | |
| CA2583742A1 (en) | 2,6-substituted-4-monosubstituted amino-pyrimidine as prostaglandin d2 receptor antagonists | |
| JP2013500267A5 (https=) | ||
| JP2004534755A5 (https=) | ||
| NZ591427A (en) | P38 map kinase inhibitors | |
| JP2007514690A5 (https=) | ||
| JP2007514003A6 (ja) | アデノシン受容体アンタゴニストとしての２，６−ビスヘテロアリール−４−アミノピリミジン | |
| JP2006528617A (ja) | ５−ｈｔ２ｂ受容体アンタゴニスト | |
| RU2001120723A (ru) | Производные имидазола и их медицинское применение |